Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02415413
What this trial is testing

Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
PETHEMA Foundation 90
Testing effectiveness (Phase 2)UnknownNCT03073694
What this trial is testing

Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis

Who this might be right for
Cancer, AppendicealColoRectal Cancer
University of Kansas Medical Center 100
Large-scale testing (Phase 3)Study completedNCT02112175
What this trial is testing

Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velcade® Induction Therapy in NDMM

Who this might be right for
Multiple Myeloma
Celgene 46
Early research (Phase 1)Looking for participantsNCT04483206
What this trial is testing

Personalized Autologous Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Emory University 90
Early research (Phase 1)Study completedNCT02390544
What this trial is testing

A Pharmacokinetic Study of Melphalan in Children

Who this might be right for
Hematopoietic Stem Cell Transplantation
Children's Hospital Medical Center, Cincinnati 34
Testing effectiveness (Phase 2)Study completedNCT00661544
What this trial is testing

Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients

Who this might be right for
Multiple MyelomaStem Cell Transplantation
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT00901238
What this trial is testing

Intra-arterial Chemotherapy(Chemosurgery) for Retinoblastoma

Who this might be right for
Retinoblastoma
Weill Medical College of Cornell University 100
Testing effectiveness (Phase 2)Ended earlyNCT03259516
What this trial is testing

Nivolumab With Chemotherapy in Refractory MDS

Who this might be right for
Myelodysplastic Syndromes
St. Petersburg State Pavlov Medical University 2
Testing effectiveness (Phase 2)Ended earlyNCT01658904
What this trial is testing

Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma

Who this might be right for
Multiple MyelomaLeukemia, Plasma Cell
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)UnknownNCT03795597
What this trial is testing

Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Loyola University 36
Testing effectiveness (Phase 2)Study completedNCT01335685
What this trial is testing

Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 61
Testing effectiveness (Phase 2)Study completedNCT01842308
What this trial is testing

Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
DS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma+1 more
Mayo Clinic 50
Testing effectiveness (Phase 2)Study completedNCT03233776
What this trial is testing

Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT

Who this might be right for
Multiple Myeloma
Radboud University Medical Center 9
Very early researchUnknownNCT02109861
What this trial is testing

Microdose Study of Melphalan, Bortezomib and Dexamethasone

Who this might be right for
Multiple Myeloma
Henrik Gregersen 6
Testing effectiveness (Phase 2)Ended earlyNCT01518153
What this trial is testing

Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphomaMyeloma+1 more
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT01605032
What this trial is testing

Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
DS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma+1 more
Albert Einstein College of Medicine 19
Large-scale testing (Phase 3)Study completedNCT00367185
What this trial is testing

Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Lille 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07259161
What this trial is testing

Modified Conditioning Regimen for CML-BP

Who this might be right for
CML,Blast PhaseHSCT
Institute of Hematology & Blood Diseases Hospital, China 40
Post-approval studies (Phase 4)Ended earlyNCT02773550
What this trial is testing

Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Basque Health Service 24
Early research (Phase 1)Study completedNCT04812470
What this trial is testing

Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 8
Next Page